Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 30 descriptions
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ABC008 | - | - | - | - | [1] 15 15 💬1. ABC008
| ||||||||||||||||||||||||||||||||||||||||||||
2 | ADSVF | - | - | - | - | [2] 15 15, 96 💬
| ||||||||||||||||||||||||||||||||||||||||||||
3 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬3. ALEMTUZUMAB
| [1] CD52 CD52 💬3. ALEMTUZUMAB
| - | [17] 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬3. ALEMTUZUMAB
| ||||||||||||||||||||||||||||||||||||||||||||
4 | Alemtuzumab (Campath) | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬4. Alemtuzumab (Campath)
| [1] CD52 CD52 💬4. Alemtuzumab (Campath)
| - | [1] 15 15 💬4. Alemtuzumab (Campath)
| ||||||||||||||||||||||||||||||||||||||||||||
5 | Anakinra | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬5. Anakinra
| [2] IL1R1 IL1R1,IL1R2 💬 | [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 [15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hem ... | [16] 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬5. Anakinra
| ||||||||||||||||||||||||||||||||||||||||||||
6 | ARIMOCLOMOL | [1] Arimoclomol Arimoclomol | [1] Arimoclomol
Arimoclomol
💬6. ARIMOCLOMOL
| - | - | [3] 2 2, 15, 19 💬
| ||||||||||||||||||||||||||||||||||||||||||||
7 | Arimoclomol citrate | [1] Arimoclomol Arimoclomol | [1] Arimoclomol
Arimoclomol
💬7. Arimoclomol citrate
| - | - | [2] 15 15, 19 💬
| ||||||||||||||||||||||||||||||||||||||||||||
8 | Bimagrumab | [1] Bimagrumab Bimagrumab | [1] Bimagrumab
Bimagrumab
💬8. Bimagrumab
| [2] ACVR2A ACVR2A,ACVR2B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathwa ... | [1] 15 15 💬8. Bimagrumab
| ||||||||||||||||||||||||||||||||||||||||||||
9 | BOTULINUM TOXIN TYPE A | [1] Botulinum toxin type A Botulinum toxin type A | [1] Botulinum toxin type A
Botulinum toxin type A
💬9. BOTULINUM TOXIN TYPE A
| [1] SNAP25 SNAP25 💬9. BOTULINUM TOXIN TYPE A
| [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [10] 2 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬9. BOTULINUM TOXIN TYPE A | ||||||||||||||||||||||||||||||||||||||||||||
10 | BRX-345 | - | - | - | - | [2] 2 2, 15 💬
|